Surfactin alleviated hyperglycaemia in mice with type 2 diabetes induced by a high-fat diet and streptozotocin

Type 2 diabetes mellitus (T2DM) is associated with liver dysfunction and intestinal dysbiosis. Bioactive peptides (BAPs) have been reported to ameliorate T2DM by preventing oxidative damage to the liver. Bacillus amyloliquefaciens fmb50 produces the lipopeptide surfactin with a wide range of biologi...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiaoyu Chen, Hongyuan Zhao, Fanqiang Meng, Libang Zhou, Zhaoxin Lu, Yingjian Lu
Format: Article
Language:English
Published: Tsinghua University Press 2023-11-01
Series:Food Science and Human Wellness
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2213453023000642
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832557754643906560
author Xiaoyu Chen
Hongyuan Zhao
Fanqiang Meng
Libang Zhou
Zhaoxin Lu
Yingjian Lu
author_facet Xiaoyu Chen
Hongyuan Zhao
Fanqiang Meng
Libang Zhou
Zhaoxin Lu
Yingjian Lu
author_sort Xiaoyu Chen
collection DOAJ
description Type 2 diabetes mellitus (T2DM) is associated with liver dysfunction and intestinal dysbiosis. Bioactive peptides (BAPs) have been reported to ameliorate T2DM by preventing oxidative damage to the liver. Bacillus amyloliquefaciens fmb50 produces the lipopeptide surfactin with a wide range of biological activities. The effects of surfactin on T2DM, on the other hand, have not been studied. In the present study, 80 mg/kg body weight surfactin supplementation lowered fasting blood glucose (FBG) levels by 21.05 % and insulin resistance (IR) by 18.18 % compared with those in the T2DM group, reduced inflammation, and increased antioxidant activity in mice with T2DM induced by a high-fat diet (HFD) and streptozotocin (STZ). According to further research, surfactin administration reduced Firmicutes-to-Bacteroidetes ratios while increasing Bifidobacterium abundance by 20 times and the level of the tight junction protein Occludin by 18.38 % and ZO-1 by 66.60 %. Furthermore, surfactin also improved hepatic glucose metabolism by activating the adenosine monophosphate-activated protein kinase (AMPK) signalling pathway, increasing glycogen synthesis and glucose transporter 2 (GLUT2) protein expression while reducing glucose-6-phosphatase (G6Pase) protein expression. In addition, the increased Bifidobacterium abundance indirectly reduced the liver burden of the metabolic products indole, cresol and amine produced by saprophytic bacteria. All of these findings revealed that surfactin not only ameliorated HFD/STZ-induced gut dysbiosis and preserved intestinal barrier integrity but also enhanced hepatic glucose metabolism and detoxification function in T2DM mice. The gut microbiota appeared to be important in controlling glucose metabolism, IR, fat accumulation, inflammation and antioxidation, according to Spearman’s correlation coefficients. All data indicated that surfactin alleviated hyperglycaemia in mice with T2DM induced by HFD/STZ.
format Article
id doaj-art-00ca4477935e44e4a1b7b94e7ecc3041
institution Kabale University
issn 2213-4530
language English
publishDate 2023-11-01
publisher Tsinghua University Press
record_format Article
series Food Science and Human Wellness
spelling doaj-art-00ca4477935e44e4a1b7b94e7ecc30412025-02-03T02:42:14ZengTsinghua University PressFood Science and Human Wellness2213-45302023-11-0112620952110Surfactin alleviated hyperglycaemia in mice with type 2 diabetes induced by a high-fat diet and streptozotocinXiaoyu Chen0Hongyuan Zhao1Fanqiang Meng2Libang Zhou3Zhaoxin Lu4Yingjian Lu5College of Food Science and Technology, Nanjing Agricultural University, Nanjing 210095, ChinaCollege of Food Science and Technology, Nanjing Agricultural University, Nanjing 210095, ChinaCollege of Food Science and Technology, Nanjing Agricultural University, Nanjing 210095, ChinaCollege of Food Science and Technology, Nanjing Agricultural University, Nanjing 210095, ChinaCollege of Food Science and Technology, Nanjing Agricultural University, Nanjing 210095, China; Corresponding authors.College of Food Science and Engineering, Nanjing University of Finance and Economics, Nanjing 210023, China; Corresponding authors.Type 2 diabetes mellitus (T2DM) is associated with liver dysfunction and intestinal dysbiosis. Bioactive peptides (BAPs) have been reported to ameliorate T2DM by preventing oxidative damage to the liver. Bacillus amyloliquefaciens fmb50 produces the lipopeptide surfactin with a wide range of biological activities. The effects of surfactin on T2DM, on the other hand, have not been studied. In the present study, 80 mg/kg body weight surfactin supplementation lowered fasting blood glucose (FBG) levels by 21.05 % and insulin resistance (IR) by 18.18 % compared with those in the T2DM group, reduced inflammation, and increased antioxidant activity in mice with T2DM induced by a high-fat diet (HFD) and streptozotocin (STZ). According to further research, surfactin administration reduced Firmicutes-to-Bacteroidetes ratios while increasing Bifidobacterium abundance by 20 times and the level of the tight junction protein Occludin by 18.38 % and ZO-1 by 66.60 %. Furthermore, surfactin also improved hepatic glucose metabolism by activating the adenosine monophosphate-activated protein kinase (AMPK) signalling pathway, increasing glycogen synthesis and glucose transporter 2 (GLUT2) protein expression while reducing glucose-6-phosphatase (G6Pase) protein expression. In addition, the increased Bifidobacterium abundance indirectly reduced the liver burden of the metabolic products indole, cresol and amine produced by saprophytic bacteria. All of these findings revealed that surfactin not only ameliorated HFD/STZ-induced gut dysbiosis and preserved intestinal barrier integrity but also enhanced hepatic glucose metabolism and detoxification function in T2DM mice. The gut microbiota appeared to be important in controlling glucose metabolism, IR, fat accumulation, inflammation and antioxidation, according to Spearman’s correlation coefficients. All data indicated that surfactin alleviated hyperglycaemia in mice with T2DM induced by HFD/STZ.http://www.sciencedirect.com/science/article/pii/S2213453023000642SurfactinType 2 diabetes mellitus (T2DM)Insulin resistanceGut microbiotaGlucose metabolism
spellingShingle Xiaoyu Chen
Hongyuan Zhao
Fanqiang Meng
Libang Zhou
Zhaoxin Lu
Yingjian Lu
Surfactin alleviated hyperglycaemia in mice with type 2 diabetes induced by a high-fat diet and streptozotocin
Food Science and Human Wellness
Surfactin
Type 2 diabetes mellitus (T2DM)
Insulin resistance
Gut microbiota
Glucose metabolism
title Surfactin alleviated hyperglycaemia in mice with type 2 diabetes induced by a high-fat diet and streptozotocin
title_full Surfactin alleviated hyperglycaemia in mice with type 2 diabetes induced by a high-fat diet and streptozotocin
title_fullStr Surfactin alleviated hyperglycaemia in mice with type 2 diabetes induced by a high-fat diet and streptozotocin
title_full_unstemmed Surfactin alleviated hyperglycaemia in mice with type 2 diabetes induced by a high-fat diet and streptozotocin
title_short Surfactin alleviated hyperglycaemia in mice with type 2 diabetes induced by a high-fat diet and streptozotocin
title_sort surfactin alleviated hyperglycaemia in mice with type 2 diabetes induced by a high fat diet and streptozotocin
topic Surfactin
Type 2 diabetes mellitus (T2DM)
Insulin resistance
Gut microbiota
Glucose metabolism
url http://www.sciencedirect.com/science/article/pii/S2213453023000642
work_keys_str_mv AT xiaoyuchen surfactinalleviatedhyperglycaemiainmicewithtype2diabetesinducedbyahighfatdietandstreptozotocin
AT hongyuanzhao surfactinalleviatedhyperglycaemiainmicewithtype2diabetesinducedbyahighfatdietandstreptozotocin
AT fanqiangmeng surfactinalleviatedhyperglycaemiainmicewithtype2diabetesinducedbyahighfatdietandstreptozotocin
AT libangzhou surfactinalleviatedhyperglycaemiainmicewithtype2diabetesinducedbyahighfatdietandstreptozotocin
AT zhaoxinlu surfactinalleviatedhyperglycaemiainmicewithtype2diabetesinducedbyahighfatdietandstreptozotocin
AT yingjianlu surfactinalleviatedhyperglycaemiainmicewithtype2diabetesinducedbyahighfatdietandstreptozotocin